Latest news & insights
Read our updates on project events, key milestones and more.
Sorry, nothing matches this category.
GLIOBREAK project officially started
The GLIOBREAK project, aiming to develop a precision immuno-epigenetic therapy for glioblastoma has officially started.
Beactica and KU Leuven collaborate in a European Innovation Council–funded project aimed at developing a new glioblastoma treatment
Beactica and KU Leuven secure EUR 2.5 million from the European Innovation Council to advance orphan drug BEA-17 to clinical readiness